Lupus Brain Fog Treatment Shows Major Promise in Trial
A new drug called EG501 significantly improved cognitive function in lupus patients during a 12-week trial, offering hope for the 80% who struggle with debilitating brain fog. Vanderbilt researchers discovered the biological cause and successfully targeted it with treatment.
